Filenews 26 February 2021
In a decision expected to significantly facilitate the disposal of Pfizer's vaccine for Covid-19, the US FDA regulator approved its storage and transfer instead of deep-freezing conditions at normal freezing temperatures for up to two weeks.
Last week Pfizer and BioNTech submitted to the FDA data that "demonstrates the stability of the vaccine" when stored at temperatures between -25 and 15 degrees Celsius, i.e. temperature of standard medical freezers and their request to relax storage instructions in deep-freezing conditions was finally accepted. "Alternative temperatures for transportation and storage will help ease the burden of supply with special equipment from vaccination centres and may help bring the vaccine to more areas," said Peter Marks, director of the FDA's Centre for Biological Evaluation and Research.
So far, EUR 66.5 million has been allocated to the project. doses of vaccines for Covid-19 in the USA, 35 million Of which Pfizer. Last December, when the FDA had turned on the green light for the emergency use of the vaccine following the relevant positive recommendation of its committee of experts, it said it had to be stored at temperatures between -60C and -80C and transported in special containers, resulting in a need for the use of special containers, which is the main logistical barrier to the distribution of the product.
Source: iefimerida.gr
